Inst Diagnosti (INDISA) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.087x

Based on the latest financial reports, Inst Diagnosti (INDISA) has a cash flow conversion efficiency ratio of 0.087x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CL$8.87 Billion ≈ $9.92 Million USD) by net assets (CL$102.41 Billion ≈ $114.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See INDISA defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Inst Diagnosti - Cash Flow Conversion Efficiency Trend (2014–2021)

This chart illustrates how Inst Diagnosti's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Inst Diagnosti Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Inst Diagnosti ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Hunan Kylinsec Technology Co. Ltd. A SHG:688152	N/A
Digi Communications NV RO:DIGI	0.085x
The Metals Royalty Company Inc. Common Stock NASDAQ:TMCR	-0.095x
DINGDONG CAYMAN 2ADR/3 A F:945	0.279x
Jiangyin Pivot Automotive Products Co. Ltd. SHE:301181	0.011x
ProCredit Holding AG & Co KGaA XETRA:PCZ	-0.342x
Laxmi Organic Industries Limited NSE:LXCHEM	0.078x
Krishana Phoschem Limited NSE:KRISHANA	-0.341x

Annual Cash Flow Conversion Efficiency for Inst Diagnosti (2014–2021)

The table below shows the annual cash flow conversion efficiency of Inst Diagnosti from 2014 to 2021. For the full company profile with market capitalisation and key ratios, see INDISA market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2021-12-31	CL$95.17 Billion ≈ $106.43 Million	CL$14.83 Billion ≈ $16.59 Million	0.156x	-8.57%
2020-12-31	CL$84.82 Billion ≈ $94.86 Million	CL$14.46 Billion ≈ $16.17 Million	0.170x	+30.98%
2019-12-31	CL$81.92 Billion ≈ $91.61 Million	CL$10.66 Billion ≈ $11.92 Million	0.130x	-32.89%
2018-12-31	CL$76.08 Billion ≈ $85.09 Million	CL$14.75 Billion ≈ $16.50 Million	0.194x	-10.15%
2017-12-31	CL$69.00 Billion ≈ $77.16 Million	CL$14.89 Billion ≈ $16.65 Million	0.216x	+17.62%
2016-12-31	CL$63.05 Billion ≈ $70.51 Million	CL$11.57 Billion ≈ $12.94 Million	0.183x	-30.86%
2015-12-31	CL$56.73 Billion ≈ $63.44 Million	CL$15.05 Billion ≈ $16.84 Million	0.265x	-2.00%
2014-12-31	CL$50.16 Billion ≈ $56.10 Million	CL$13.58 Billion ≈ $15.19 Million	0.271x	--

About Inst Diagnosti

SN:INDISA Chile Medical Care Facilities

Market Cap

$459.61 Million

CL$410.98 Billion CLP

Market Cap Rank

#12869 Global

#55 in Chile

Share Price

CL$2678.60

Change (1 day)

-0.76%

52-Week Range

CL$2106.10 - CL$2889.90

All Time High

CL$2889.90